Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells

Cardiovascular Research

Volumn 73, Issue 1, 2007, Pages 208-216

  Camino Lopez S ^a   Llorente Cortes V ^a   Sendra, J ^a   Badimon, L ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Aggregated LDL; LRP1; Statins; Thrombosis; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 10A; EXOENZYME C3; FARNESYL DIPHOSPHATE; GERANYLGERANYL PYROPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PROCOAGULANT; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SIMVASTATIN; THROMBOPLASTIN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ADP RIBOSE TRANSFERASES; ANTIBODIES, MONOCLONAL; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; BOTULINUM TOXINS; CELL MEMBRANE; CELLS, CULTURED; CORONARY VESSELS; CYTOPLASM; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOHISTOCHEMISTRY; LDL-RECEPTOR RELATED PROTEIN 1; LIPOPROTEINS, LDL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; POLYISOPRENYL PHOSPHATES; RAC1 GTP-BINDING PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHOA GTP-BINDING PROTEIN; SESQUITERPENES; SIMVASTATIN; THROMBOPLASTIN;

EID: 33845586634     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.10.017     Document Type: Article

References (34)

1. Nemerson Y. Tissue factor and hemostasis. Blood 71 (1988) 1-8
2. Fuster V., Stein B., Ambrose J.A., Badimon L., Badimon J.J., and Chesebro J.H. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 82 (1990) II47-II59
3. Toschi V., Gallo R., Lettino M., Fallon J.T., Gertz S.D., Fernandez-Ortiz A., et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95 (1997) 594-599
4. Moreno P.R., Bernardi V.H., Lopez-Cuellar J., Murcia A.M., Palacios I.F., Gold H.K., et al. Macrophages, smooth muscle cells and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 94 (1996) 3090-3097
5. Camejo G., Hurt-Camejo E., Wiklund O., and Bondjers G. Association of apoB lipoprotein with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 139 (1998) 205-222
6. Guyton J.R., Klemp K.F., and Mims M.P. Altered ultrastructural morphology of self-aggregated low density lipoproteins. Coalescence of lipid domains forming droplets and vesicles. J Lipid Res 32 (1991) 953-961
7. Cui M.Z., Penn M.S., and Chisolm G.M. Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1. J Biol Chem 274 (1999) 32795-32802
8. Penn M.S., Patel C.V., Cui M.Z., DiCorleto P.E., and Chisolm G.M. LDL increases inactive tissue factor on vascular smooth muscle cell surfaces: hydrogen peroxide activates latent cell surface tissue factor. Circulation 99 (1999) 1753-1759
9. Llorente-Cortés V., Otero-Viñas M., Camino-López S., Llampayas O., and Badimon L. Aggregated low density lipoprotein uptake induces tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells. Circulation 110 (2004) 452-459
10. Llorente-Cortés V., Otero-Viñas M., Hurt-Camejo E., Martínez-González J., and Badimon L. Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors. Arterioscler Thromb Vasc Biol 22 (2002) 387-393
11. Llorente-Cortés V., Otero-Viñas M., Sánchez S., Rodriguez C., and Badimon L. Low density lipoprotein up-regulates low density lipoprotein receptor-related protein expression in vascular smooth muscle cells. Possible involvement of sterol regulatory element binding protein-2-dependent mechanism. Circulation 106 (2002) 31104-31110
12. Llorente-Cortés V., Otero-Viñas M., Camino-López S., Costales P., and Badimon. Cholesteryl esters of aggregated LDL are internalized by selective uptake in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 26 (2006) 117-123
13. Llorente-Cortés V., and Badimon L. LDL receptor-related protein and the vascular wall. Arterioscler Thromb Vasc Biol 25 (2005) 497-504
14. Mallat Z., and Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res 88 (2001) 998-1003
15. Tedgui A., and Mallat Z. Smooth muscle cells: another source of tissue factor-containing microparticles in atherothrombosis?. Circ Res 87 (2000) 81-82
16. Rosenson R.S., and Brown A.S. Statin use in acute coronary syndromes: cellular mechanisms and clinical evidence. Curr Opin Lipidol 13 (2002) 625-630
17. Bea F., Blessing E., Shelley M.I., Shultz J.M., and Rosenfeld M.E. Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation. Atherosclerosis 167 (2003) 187-194
18. Camera M., Toschi V., Comparato C., Baetta R., Rossi F., and Fuortes M. Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin. Thromb Haemost 87 (2002) 748-755
19. Aikawa M., and Libby P. Lipid lowering reduces proteolytic and prothrombotic potential in rabbit atheroma. Ann N Y Acad Sci 902 (2000) 140-152
20. Baetta R., Camera M., Comparato C., Altana C., Ezekowitz M.D., and Tremoli E. Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the presence of lipid lowering. Arterioscler Thromb Vasc Biol 22 (2002) 692-698
21. Casani L., Sanchez-Gomez S., Vilahur G., and Badimon L. Pravastatin reduces thrombogenicity by mechanisms beyond plasma cholesterol lowering. Thromb Haemost 94 (2005) 1035-1041
22. Seasholtz T.M., and Brown J.H. Rho signaling in vascular diseases. Mol Interv 4 (2004) 348-357
23. Key N.S., Slungaard A., Dandelet L., Nelson S.C., Moertel C., Styles L.A., et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 91 (1998) 4216-4223
24. Giesen P.L., Rauch U., Bohrmann B., Kling D., Roque M., Fallon J.T., et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 92 (1999) 2311-2315
25. Nagata K., Ishibashi T., Sakamoto T., Ohkawara H., Shindo J., Yokoyama K., et al. Rho/Rho-kinase is involved in the synthesis of tissue factor in human monocytes. Atherosclerosis 163 (2002) 3947
26. Eto M., Kozai T., Cosentino F., Joch H., and Luscher T.F. Statin prevents tissue factor expression in human endothelial cells. Circulation 105 (2002) 1756-1759
27. Ishibashi T., Sakamoto T., Ohkawara H., Nagata K., Sugimoto K., Sakurada S., et al. Integral role of RhoA activation in monocyte adhesion-triggered tissue factor expression in endothelial cells. Arterioscler Thromb Vasc Biol 23 (2003) 681-687
28. Ma Z., Thomas K.S., Webb D.J., Moravec R., Salicioni A.M., Mars W.M., et al. Regulation of Rac1 activation by the low density lipoprotein receptor-related protein. J Cell Biol 159 (2002) 1061-1070
29. Holstein S.A., Wohlford-Lenane C.L., and Hohl R.J. Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, and RhoB. J Biol Chem 277 (2002) 10678-10682
30. Leonard S., Beck L., and Sinensky M. Inhibition of isoprenoid biosynthesis and the post-translational modification of pro-p21. J Biol Chem 265 (1990) 5157-5160
31. Penn M.S., Patel C.V., Cui M.-.Z., DiCorleto P.E., and Chisolm G.M. LDL increases inactive tissue factor on vascular smooth muscle cell surfaces: hydrogen peroxide activates latent cell surface tissue factor. Circulation 99 (1999) 1753-1759
32. Zhu S., Viswambharan H., Gajanayake T., Ming X.F., and Yang Z. Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells. BMC Cardiovasc Disord 22 (2005) 1-7
33. Bach R.R., and Moldow C.F. Mechanism of tissue factor activation on HL-60 cells. Blood 89 (1997) 3270-3276
34. Schecter A.D., Giesen P.L., Taby O., Rosenfield C.L., Rossikhina M., Fyfe B.S., et al. Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest 100 (1997) 2276-2285